EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Recommendations on prevention of infections during chimeric antigen receptor T ‐cell and bispecific antibody therapy in multiple myeloma

Meera Mohan iD, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic iD, Anita D'Souza iD, Peter G Pappas, Jesus G Berdeja, Natalie Callander, Luciano J Costa iD

British Journal of Haematology · 2023-12 · 203 (5) · 736-746

DOI: 10.1111/bjh.18909 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Haematology, online erschienen am 07.06.2023. Verfasst von Meera Mohan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Multiple Myeloma, Antibodies, Bispecific, Leukopenia. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T (CAR T) cell and bispecific antibody therapies have shown unprecedented efficacy in heavily pretreated patients with multiple myeloma (MM). However, their use is associated with a significant risk of severe infections, which can be attributed to various factors such as hypogammaglobulinemia, neutropenia, lymphopenia, T‐cell exhaustion, cytokine‐release syndrome and immune‐effector cell‐associated neurotoxicity syndrome. As these therapies have been recently approved by regulatory agencies, it is crucial to establish practical guidelines for infection monitoring and prevention until robust data from prospective clinical trials become available. To address this issue, a panel of experienced investigators from the Academic Consortium to Overcome Multiple Myeloma through Innovative Trials (COMMIT) developed consensus recommendations for mitigating infections associated with CAR T‐cell and bispecific antibody therapies in MM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenMultiple MyelomaAntibodies, BispecificLeukopeniaHumansT-LymphocytesProspective StudiesImmunotherapy, AdoptiveB-Cell Maturation AntigenNeurotoxicity Syndromes

Stichwörter der Autor:innen

bispecific T-cellchimeric antigen receptor T-cellimmunotherapyinfectionmultiple myeloma

Substanzen

Receptors, Chimeric Antigencell-associated neurotoxicityAntibodies, BispecificB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University, New York City, New York, USA.
  • Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
  • Sarah Cannon Research Institute, Nashville, Tennessee, USA.

ORCID-Profile: Meera Mohan, Muhamed Baljevic, Anita D'Souza, Luciano J Costa

Förderung

  • NCI NIH HHS

Zitieren

APA

Mohan, M., Chakraborty, R., Bal, S., Nellore, A., Baljevic, M., D'Souza, A., Pappas, P. G., Berdeja, J. G., Callander, N., & Costa, L. J. (2023). Recommendations on prevention of infections during chimeric antigen receptor T ‐cell and bispecific antibody therapy in multiple myeloma. British Journal of Haematology, 203(5), 736-746. https://doi.org/10.1111/bjh.18909

Vancouver

Mohan M, Chakraborty R, Bal S, Nellore A, Baljevic M, D'Souza A, et al. Recommendations on prevention of infections during chimeric antigen receptor T ‐cell and bispecific antibody therapy in multiple myeloma. British Journal of Haematology. 2023;203(5):736-746. doi:10.1111/bjh.18909

BibTeX
@article{Mohan2023,
  author = {Mohan, Meera and Chakraborty, Rajshekhar and Bal, Susan and Nellore, Anoma and Baljevic, Muhamed and D'Souza, Anita and Pappas, Peter G and Berdeja, Jesus G and Callander, Natalie and Costa, Luciano J},
  title = {Recommendations on prevention of infections during chimeric antigen receptor T ‐cell and bispecific antibody therapy in multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {203},
  number = {5},
  pages = {736--746},
  doi = {10.1111/bjh.18909}
}
Kostenlos starten →